{"id":7137,"date":"2025-05-22T14:20:53","date_gmt":"2025-05-22T11:20:53","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=7137"},"modified":"2025-05-22T14:20:53","modified_gmt":"2025-05-22T11:20:53","slug":"same-day-discharge-after-tavr-safe-and-effective-in-selected-patients","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/same-day-discharge-after-tavr-safe-and-effective-in-selected-patients\/","title":{"rendered":"Same-Day Discharge After TAVR: Safe and Effective in Selected Patients"},"content":{"rendered":"<div>Same-Day Discharge After TAVR: Safe and Effective in Selected Patients<\/div>\n<div>Source: Canadian Journal of Cardiology<\/div>\n<div>Date: May 16 , 2025<\/div>\n<div><\/div>\n<div>The Canadian Journal of Cardiology (official journal of CCS) is now included in our academic exchange and collaboration framework with the Jordanian Cardiac Society (JCS).<\/div>\n<div>Key Points:<\/div>\n<div><span> 1. Study Overview:<\/span><\/div>\n<div><span> \u2022 Meta-analysis of over 35,000 patients from 6 studies.<\/span><\/div>\n<div><span> \u2022 Compared same-day discharge (SDD) vs next-day discharge (NDD) after transfemoral TAVR.<\/span><\/div>\n<div><span> 2. Patient Profile:<\/span><\/div>\n<div><span> \u2022 Mean age: 78.2 years.<\/span><\/div>\n<div><span> \u2022 59.3% male.<\/span><\/div>\n<div><span> \u2022 91.6% received balloon-expandable valves; only 8.4% self-expanding.<\/span><\/div>\n<div><span> 3. Outcomes After 30 Days:<\/span><\/div>\n<div><span> \u2022 SDD linked to lower:<\/span><\/div>\n<div><span> \u2022 Mortality.<\/span><\/div>\n<div><span> \u2022 All-cause readmission.<\/span><\/div>\n<div><span> \u2022 Cardiovascular readmission.<\/span><\/div>\n<div><span> \u2022 Pacemaker implantation.<\/span><\/div>\n<div><span> \u2022 Stroke and vascular complications: no significant difference vs NDD.<\/span><\/div>\n<div><span> 4. Why SDD Works:<\/span><\/div>\n<div><span> \u2022 Stroke risk is highest in first 4\u20136 hours post-procedure, then declines.<\/span><\/div>\n<div><span> \u2022 Advances in vascular closure devices improve safety.<\/span><\/div>\n<div><span> 5. Who qualifies for same-day discharge?<\/span><\/div>\n<div>Selected patients for SDD are those who meet strict clinical criteria ensuring safety. These include conscious sedation, no procedural complications, stable vital signs and ECG within 4\u20136 hours, independent ambulation, sufficient home support, and proximity to the hospital. Patients must not have pre-existing conduction abnormalities or require a pacemaker. Most studies supporting SDD involved balloon-expandable valves, with limited data on self-expanding valves. Careful selection remains key.<\/div>\n<div><span> 6. Limitation:<\/span><\/div>\n<div><span> \u2022 Lack of data on SDD with self-expanding valves.<\/span><\/div>\n<div><span> \u2022 More research needed for this subgroup.<\/span><\/div>\n<div><span> 7. Conclusion:<\/span><\/div>\n<div><span> \u2022 Same-day discharge is viable and safe for low-risk, elective transfemoral TAVR patients.<\/span><\/div>\n<div><span> \u2022 Careful selection and follow-up remain essential.<\/span><\/div>\n<div><\/div>\n<div>Link to Full Article:<\/div>\n<div><a href=\"https:\/\/www.cardiovascularbusiness.com\/topics\/structural-heart-disease\/same-day-discharge-tavr-positive-outcomes\">https:\/\/www.cardiovascularbusiness.com\/topics\/structural-heart-disease\/same-day-discharge-tavr-positive-outcomes<\/a><\/div>\n<div><a href=\"https:\/\/onlinecjc.ca\/article\/S0828-282X(25)00342-3\/fulltext\">https:\/\/onlinecjc.ca\/article\/S0828-282X(25)00342-3\/fulltext<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Same-Day Discharge After TAVR: Safe and Effective in Selected Patients Source: Canadian Journal of Cardiology Date: May 16 , 2025 The Canadian Journal of Cardiology (official journal of CCS) is now included in our academic exchange and collaboration framework with the Jordanian Cardiac Society (JCS). Key Points: 1. Study Overview: \u2022 Meta-analysis of over 35,000 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7137","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=7137"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7137\/revisions"}],"predecessor-version":[{"id":7138,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7137\/revisions\/7138"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=7137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=7137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=7137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}